# FDA Inspection 1079942 - Summa Health System - February 14, 2019

Source: https://www.keypedia.com/records/fda_inspections/summa-health-system/b5136cde-7564-486a-ba6b-8ca15cd03d40
Source feed: FDA_Inspections

> FDA Inspection 1079942 for Summa Health System on February 14, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1079942
- Company Name: Summa Health System
- Inspection Date: 2019-02-14
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1261356 - 2025-02-11](https://www.keypedia.com/records/fda_inspections/summa-health-system/ac10336a-25f3-4e83-9d83-74f2e0cbdeaa)
- [FDA Inspection 1261356 - 2025-02-11](https://www.keypedia.com/records/fda_inspections/summa-health-system/0b5ea2d9-06ba-4ec2-af6d-156d628e146b)
- [FDA Inspection 1200440 - 2023-03-21](https://www.keypedia.com/records/fda_inspections/summa-health-system/67e5e470-47a6-4280-9176-66734b153418)
- [FDA Inspection 1200440 - 2023-03-21](https://www.keypedia.com/records/fda_inspections/summa-health-system/63628b96-5525-49ed-badf-07bcdaf684b6)
- [FDA Inspection 998458 - 2017-01-27](https://www.keypedia.com/records/fda_inspections/summa-health-system/435fa3a4-007f-4b82-bdcf-23ded40d60b8)

Company: https://www.keypedia.com/companies/summa-health-system/8d7bf562-d4ca-4beb-ad6f-648e9888c0ef

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d